{
    "2019-08-21": [
        [
            {
                "time": "",
                "original_text": "贝达药业：公司埃克替尼纳入国家医保药品目录",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "埃克替尼",
                        "国家医保",
                        "药品目录"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "早间公告：贝达药业、华森制药产品纳入国家医保《药品目录》",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "华森制药",
                        "产品",
                        "国家医保",
                        "药品目录"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}